NCT07177352 Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
| NCT ID | NCT07177352 |
| Status | Recruiting |
| Phase | Phase 3 |
| Sponsor | Hoffmann-La Roche |
| Condition | Alzheimers Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 13,000 participants |
| Start Date | 2025-07-02 |
| Primary Completion | 2035-07-31 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
This study is a pre-screening process used to assess participants' potential eligibility for Roche interventional Alzheimer's disease studies.
Eligibility Criteria
Inclusion Criteria: \- Report of objective or subjective memory concerns (by the participant and/or their informant) within the last year with or without a previous clinical diagnosis of MCI or dementia due to AD. Exclusion Criteria: * Dependency in basic activities of daily living (bADLs) due to cognitive impairment * Visual or auditory impairment that would prevent them from performing the cognitive assessments (eyeglasses and hearing aids are permitted) * Any self-reported evidence or known diagnosis of a neurological or neurodegenerative condition that may lead to cognitive impairment other than AD * History of severe, clinically significant central nervous system trauma * Any serious medical condition that precludes a participant's safe participation and completion of a clinical study
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.